FdaApplication
NDA 206073
Identifiers
- fda_app_no: NDA206073
Properties
| Property | Value |
|---|---|
| applicant_name | BOEHRINGER INGELHEIM |
| application_type | NDA |
| approval_date | 2015-01-30 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| GLYXAMBI | EMPAGLIFLOZIN; LINAGLIPTIN | 10MG;5MG | TABLET;ORAL |
| GLYXAMBI | EMPAGLIFLOZIN; LINAGLIPTIN | 25MG;5MG | TABLET;ORAL |
2 products